Pacific biosciences of california stock.

In other Pacific Biosciences of California news, insider Christian O. Henry sold 96,844 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $10.12, for a total value of $980,061.28.S&P 500 U.S. 10 Yr Barron's 400 Market Data Stocks PACB Overview Pacific Biosciences of California Inc. U.S.: Nasdaq About Pacific Biosciences of California …Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...Pacific Biosciences Of California Inc. (NASDAQ: PACB) is a biotechnology company. In the last three months, Pacific Biosciences Of California Inc. (NASDAQ: PACB) stock gained 182% and on February ...

Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ...During the last session, Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares were 3.39 million, with the beta value of the company hitting 1.79. At the end of the trading day, the stock’s price was $8.48, reflecting an intraday loss of -3.53% or -$0.31. The 52-week high for the ...

MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.

١٢‏/١٠‏/٢٠٢٣ ... Shares of Pacific Biosciences of California (PACB) - Get Free Report, a life science technology company focused on solving genetic problems, ...Common Stock, par value $0.001 per share. PACB. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, …As of November 1, 2023, Canaccord Genuity analyst Kyle Mikson has reaffirmed a Buy rating on Pacific Biosciences (NASDAQ:PACB), although ... Best stocks to buy now; Categories. Crypto; Dow Jones today; Pre-IPO and startups; Tech stocks; Utility stocks; Best Stocks tools HOT. Stock News Sentiment;Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ...

Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business.

The Relative Strength (RS) Rating for Pacific Biosciences of California stock jumped into a new percentile Wednesday, with a rise from 70 to 84.. X. When looking for the best stocks to buy and ...

Also Known As Nanofluidics, Pacific Biosciences. Legal Name Pacific Biosciences of California, Inc. Stock Symbol NASDAQ:PACB. Company Type For Profit. Contact Email [email protected]. Phone Number 650-618-2699. PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its …A steep rise in short interest was recorded in Pacific Biosciences of California Inc stocks on Oct 30, 2023, growing by 2.05 million shares to a total of 35.12 million shares. Yahoo Finance data shows the prior-month short interest on Sep 28, 2023 was 33.07 million shares. There was a rise of 5.84%, which implies that there is a …The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering.Industry Rank: Top 29% (74 out of 251) Industry: Medical - Instruments. Pacific Biosciences of California (PACB) Quote Overview » More Research » Pacific Biosciences of California (PACB ...Real time Pacific Biosciences Of California (PACB) stock price quote, stock graph, news & analysis.Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.

In other news concerning Pacific Biosciences of California, insider Michele Farmer sold 5,165 shares of the company’s stock on May 18th at an average price of $12.59 per share, resulting in a total transaction value of $65,027.35. Following this sale, Farmer now holds 107,577 shares of PACB stock with an approximate value of $1,354,394.43.24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...In other news, insider Susan G. Kim sold 19,257 shares of Pacific Biosciences of California stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $8.44 ...Sep 18, 2023 · One such stock that merits attention is Pacific Biosciences of California Inc (NASDAQ:PACB). The stock, which is currently priced at 10.06, recorded a loss of 3.5% in a day and a 3-month decrease ... Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...

MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the …

The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Institutional investors purchased a net $7.8 million shares of PACB during the quarter ended June 2019 and now own 98.90% of the total shares outstanding. This ...The entire state of California is located within the Pacific time zone. As of 2014, the state observes Pacific Standard Time between the middle of the fall and the end of the winter. At all other times, Pacific Daylight Time is observed.١٢‏/١٠‏/٢٠٢٣ ... Shares of Pacific Biosciences of California (PACB) - Get Free Report, a life science technology company focused on solving genetic problems, ...Pacific Biosciences of California is forecast to grow earnings and revenue by 30.8% and 30.6% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be -58.8% in 3 years.Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s stock price dropped 4% on Monday .The company traded as low as $8.14 and last traded at $8.21. Approximately 282,223 ...Apr 30, 2021 · PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ... The stock price of Pacific Biosciences of California, a biotechnology company that develops gene sequencing systems, has seen a large fall of 38% over the last twenty-one trading days, while it is ...Overview News Pacific Biosciences of California Inc. No significant news for in the past two years. Shares Sold Short 35.12 M Change from Last -6.95% Percent of Float 13.74% …Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.76. At the close of trading, the stock’s price was $8.36, to imply an increase of 0.97% or $0.08 in intraday trading.

Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Pacific Biosciences of California Inc (NASDAQ: PACB) has experienced a rise in its stock price by 4.67 compared to its previous closing price of 8.36. However, the company has seen a gain of 15.28% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-20 that Pacific Biosciences reported a 72% YoY […]

Nov 14, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44. Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 …Apr 11, 2023 · April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ... Pacific Biosciences of California Stock Earnings. The value each PACB share was expected to gain vs. the value that each PACB share actually gained. PACB ( PACB) reported Q3 2023 earnings per share (EPS) of -$0.26, beating estimates of -$0.29 by 9.37%. In the same quarter last year, PACB 's earnings per share (EPS) was -$0.34.Pacific Biosciences of California Inc (PACB). Industry Medical Devices. Deal. This stock can be held in an Investment ISA and an Investment Account. Sell. $6.55.MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...

Reassessing Pacific Biosciences: Deep Dive Into Q3 2023 Revenue Surge And Market Dynamics 11/20/23-9:07AM EST Seeking Alpha Pacific Biosciences of California rises after UBS upgrades on strong ...Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44.Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ...Of course Pacific Biosciences of California may not be the best stock to buy.So you may wish to see this free collection of growth stocks.. Please note, the market returns quoted in this article ...Instagram:https://instagram. most prestigious investment banksquarters that have valuebaron'sbest place to sell a laptop UBS Upgrades Pacific Biosciences of California to Buy From Neutral, Cuts Price Target to $10 From $13. Nov. 17. MT. Piper Sandler Trims Price Target on Pacific Biosciences of … free mobile banking appstop forex frokers Raised approximately $201 million in gross proceeds in an upsized public offering of common stock in January 2023. ... Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve …Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85. bitwise stock KGI Securities started coverage on Pacific Biosciences of California and gave it an “outperform” rating in their report released on Wednesday June 7th. Morgan Stanley increased its price target for Pacific Biosciences of California from $12.00 to $13.00 and gave the stock an “equal weight” rating in their report on Thursday, August 3rd.Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.